FDA Issues EUA for Pfizer Covid-19 Vaccine
Inoculations could begin early next week WASHINGTON — The FDA granted emergency use authorization...
Read More
FDA / Research
Adding Anti-Inflammatory to Remdesivir Improved Covid-19 Outcomes
Faster recovery reported with baricitinib/remdesivir therapy in ACTT-2 Among patients hospitalized...
Read More
Cancer Patients More At Risk for Covid-19 Infection than Those without Cancer
Patients with a recent cancer diagnosis were the most vulnerable at-risk group for Covid-19...
Read More
FDA Advisory Committee Recommends Approving EUA for Pfizer Covid-19 Vax
Unblinding concerns and vaccinating special populations remain issues WASHINGTON — The FDA had...
Read More
Covid-19: Trial Confirms 95% Protection with Pfizer Vaccine
Peer-reviewed data reported in NEJM Peer-reviewed findings from a multinational trial of Pfizer’s...
Read More
Covid-19: FDA Approves First OTC, At-Home Coronavirus Test
Test available for adult use without prescription WASHINGTON — The FDA granted an emergency use...
Read More
What Seniors Can Expect When COVID Vaccines Begin to Roll Out
At least two vaccines could get federal emergency use authorizations this month. Nursing home and assisted living residents will be among the first to receive inoculations. Here’s a guide on how that rollout may proceed.
Read More
Interim Data Suggests AstraZeneca Covid-19 Vaccine Effective, Safe
But early missteps leave some questioning findings Interim results showed the Oxford-AstraZeneca...
Read More
Metformin Use May Reduce Mortality in Women With COVID-19
WEDNESDAY, Dec. 9, 2020 (HealthDay News) — For women with type 2 diabetes or obesity who are...
Read More
Hospitalization Up for Black Gynecologic Cancer Patients With COVID-19
WEDNESDAY, Dec. 9, 2020 (HealthDay News) — Black gynecologic oncology patients with COVID-19...
Read More
COVID-19 Vaccine Caution Issued by U.K. Officials
WEDNESDAY, Dec. 9, 2020 (HealthDay News) — People with a “significant history”...
Read More
Canada Approves Pfizer COVID-19 Vaccine
WEDNESDAY, Dec. 9, 2020 (HealthDay News) — The Pfizer COVID-19 vaccine has been approved by...
Read More
Covid-19: No Transmission Risk from Young Kids for Adult Care Providers
Research adds support to previous findings, but should not be generalized to older age groups...
Read More
Covid-19: U.K. Warns of Allergic Reactions in Two Pfizer Vax Recipients
Health authorities urge patients with history of allergic reactions to steer clear U.K. health...
Read MoreTracking COVID’s Spread Inside a Tight-Knit Latino Community
Contact tracing for COVID-19 in a Latino immigrant community has some unique challenges. But as public health officials in Telluride, Colorado, are showing, using resources from inside those communities can help track and contain the coronavirus.
Read More
Covid-19: Mother-to-Infant Transmission Rare
Small Italian study supports rooming-in and breastfeeding during pandemic New moms with Covid-19...
Read More
Mental Health Symptoms Common for Perinatal Women During COVID-19
THURSDAY, Dec. 3, 2020 (HealthDay News) — Mental health symptoms are common among perinatal...
Read More
Visceral Adiposity & COVID-19 Severity
Data indicate that, depending on the degree of obesity, patients with obesity who are infected...
Read More
WHO Trial Finds No Covid-19 Mortality Benefit for Antiviral Drugs
Antivirals, including remdesiver, failed to reduce ventilation, or length-of-stay Covid-19...
Read MoreHow COVID-19 Highlights the Uncertainty of Medical Testing
Widespread COVID testing has revealed uncomfortable truths about medical tests: A test result is rarely a definitive answer, but instead a single clue. A result may be falsely positive or negative, or it may show an abnormality that doesn’t matter. And as COVID testing has made too clear, even an accurate, meaningful result is useless unless it’s acted on appropriately.
Read More